MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2026 International Congress

    Item – Level Drivers of Certification Failure in the MDS-UPDRS Motor Examination: A Five-Year Global Analysis

    C. Falup-Pecurariu, C. Akbostanci, E. Bayram, I. Estrada-Bellmann, J. Ma, T. Mestre, I. Murasan, O. Ojo, P. Pal, M. Qamar, F. Rodriguez-Porcel, A. Sanchez Ferro (Brasov, Romania)

    Objective: To identify individual Part III items that disproportionately contribute to first-attempt certification failure and to evaluate the stability of these patterns over five years.…
  • 2026 International Congress

    Clinical instability and fluctuations as an early marker of accelerated progression

    A. Beltrán-Torres, M. Rocha-de-León, K. Sánchez-Ramírez, N. Sánchez-Lorenzo, A. Cervantes-Arriaga, M. Rodríguez-Violante (Monterrey, Mexico)

    Objective: To determine whether early clinical instability, quantified through combined motor and non-motor fluctuations, predicts a more severe longitudinal disease course in Parkinson’s disease. Background:…
  • 2026 International Congress

    Exploring a Milestone-Based Approach as an Outcome Measure for Disease-Modifying Parkinson Disease Trials

    C. Gonzalez-Robles, M. Burnell, A. Schrag, R. Weil, G. Mills, ML. Zeissler, J. Carpenter, S. Gandhi, C. Carroll, T. Foltynie (London, United Kingdom)

    Objective: To replicate a composite milestone(CM) approach in a range of Parkinson Disease(PD) studies(observational, clinical trials) over a long time period(up to 12 years). To…
  • 2026 International Congress

    Associations Between FDG-PET Regional Metabolism and Clinical Severity in Progressive Supranuclear Palsy

    M. Oliveira, V. Maciel, G. Martins, C. Carneiro, C. Buchpiguel, A. Coutinho, J. Parmera, E. Barbosa (São Paulo, Brazil)

    Objective: To characterize the clinical profile, disease progression, and their associations with neuroimaging biomarkers in patients with Progressive Supranuclear Palsy (PSP). Background: PSP encompasses a…
  • 2026 International Congress

    Patient-Defined Disease Progression in Parkinson Disease: Towards Patient-Relevant Outcome Measures

    C. Gonzalez-Robles, A. Schrag, R. Weil, M. Burnell, G. Mills, ML. Zeissler, J. Carpenter, S. Gandhi, C. Carroll, T. Foltynie (London, United Kingdom)

    Objective: To carry out a survey on a representative sample of people with Parkinson’s (PwP) about their lived experience of a comprehensive list of Parkinson…
  • 2026 International Congress

    Beyond Motor Outcomes: Health Literacy, Medication Adherence, and Quality of Life in Parkinson’s Disease Patients Undergoing the Levodopa Challenge Test

    M. da Silva, M. Tosin, L. Silveira-Moriyama (Campinas, Brazil)

    Objective: To characterize health literacy (HL), medication adherence, satisfaction with medication information, and quality of life (QoL) in Parkinson’s disease (PD) patients undergoing the levodopa…
  • 2026 International Congress

    Prospective Evaluation of a Video-Based Motor Assessment Workflow: Feasibility, Usability, and Data Quality

    B. Bridges, O. Hares, E. Nishat, R. Nasir, R. Singh (St. John's, Canada)

    Objective: To prospectively evaluate the feasibility, usability, and data quality of a video-based motor assessment platform (PRIMS) in a clinic setting, and to examine agreement…
  • 2026 International Congress

    Interplay of sex and GBA1 and LRRK2 genotype in Parkinson disease progression

    J. Park, M. Yang, N. Masood, R. Ortega, D. Raymond, A. Wise, B. Green, K. Leaver, V. Katsnelson, V. Shanker, M. Swan, M. Pullman, A. Domingo, L. Ozelius, S. Bressman, C. Wang, R. Saunders-Pullman (New York, USA)

    Objective: To characterize disease heterogeneity and how sex impacts motor and cognitive progression class membership across genetic subgroups of GBA1, LRRK2, and idiopathic Parkinson disease (PD). Background: Autosomal…
  • 2025 International Congress

    Automating the assessment of motor symptoms of Parkinson’s: exploring the scope of assessment possible in a video-based approach.

    A. Podlewska, R. Singh, M. Squires, B. Bridges (London, United Kingdom)

    Objective: To explore the scope of the PRIMS assessment in People with Parkinson’s (PwP), including symptom severity rating, assessment time, individual assessment item completion and…
  • 2025 International Congress

    Clinical Characteristics of Parkinsons Disease and their Role in Differential Diagnosis

    M. Ganieva, L. Tolibova (Dushanbe, Tajikistan)

    Objective: To study and systematize the clinical characteristics of Parkinson's disease (PD) and their role in differential diagnosis with other parkinsonian syndromes. Background: Parkinson’s disease…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 39
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley